Month: February 2026

Whole Body MRI and PSMA PET-CT scans each offer unique insights into advanced prostate cancer. Discover how these imaging methods compare in finding cancer spread beyond the prostate gland. keep reading

After focal therapy for prostate cancer, annual PSA testing and mpMRI scans work together to spot new cancer activity. This approach offers a balance of cancer control and quality of life, keeping future treatment options open for patients and their doctors. keep reading

Artificial Intelligence is reshaping prostate cancer care, from more accurate screening and early detection to optimizing treatment strategies. New research highlights four major clinical areas where AI is already making a measurable difference in diagnosis, risk assessment, and therapy planning. keep reading

Whole Body MRI and PSMA-PET scans are leading tools for detecting prostate cancer that has spread beyond the gland. Recent studies suggest Whole Body MRI may hold a slight edge in accuracy, especially for predicting risk and tracking treatment, while both remain vital for planning care. keep reading

Could where fat collects on the body matter more for cancer risk than overall weight? While researchers have linked high BMI to more aggressive prostate cancer, new measures like A Body Shape Index reveal stronger ties to colon cancer. Evidence remains mixed for prostate cancer, keeping healthy habits as the best defense. keep reading

MRI-based diagnosis offers a more accurate and less invasive path for prostate cancer detection than traditional methods. By identifying clinically significant tumors before biopsy, the MRI pathway helps prevent overtreatment while safeguarding quality of life. keep reading